Vol. 17/No. 23 | OncologyLive

The Search for Partners

December 05, 2016

These days, no one is talking about finding such a simplistic answer for what we now understand is a set of diseases whose complexity continues to unfold. Instead, it has become the norm to think about emerging oncology paradigms in terms of combination therapies.

Novel Agent Anchors Triplet Regimen in Ovarian Cancer Trial

December 01, 2016

A multipronged attack on the tumor vasculature network is at the heart of a recently launched clinical trial aimed at developing new therapeutic options for women with advanced, recurrent, platinum-resistant ovarian cancer.

IDO Inhibitors Among Immunotherapy Strategies Under Study in Glioblastoma

November 30, 2016

The concept of using immunotherapies to treat patients with glioblastoma multiforme is gaining ground among researchers who are interested not only in evaluating checkpoint blockade agents that have proved effective in other tumor types but also in exploring novel targets.